Effecting M&A Diligence When Competitors Are Involved
Increased scrutiny of the healthcare industry from antitrust agencies such as the Federal Trade Commission and US Department of Justice
Read MoreIncreased scrutiny of the healthcare industry from antitrust agencies such as the Federal Trade Commission and US Department of Justice
Read MoreIntroduction In April 2024, the President of the Office of Competition and Consumers Protection (the “PCA”) introduced new guidelines for
Read MoreThe Brazilian Competition Authority – CADE – has just recently published its Guidelines for Non-Horizontal Merger Reviews, which consolidate and
Read MoreMany of the most challenging transactions reviewed under the EU Merger Regulation (EUMR) in recent years involved their likely effects
Read MoreEurope has been a frontrunner in the regulation of artificial intelligence on a global scale. The adoption of the Artificial
Read MoreThe health care industry has been a particular focus of antitrust concern in recent years, including recent policy initiatives, private
Read MoreAs it marked the 30-year anniversary of the Single Market, the European Council asked former Italian Prime Minister, Enrico Letta,
Read MoreIntroduction In 2023, the ACM has again shown its commitment to enforcing competition law with the aim of protecting the
Read MoreAccording to the German philosopher Johann Gottfried Herder, the two greatest tyrants on Earth are chance and time. The word
Read MoreThe DMA seeks to capture gatekeeper conduct. For that, the regulation applies to those targets of the regulation satisfying the
Read More